Clinical Trials Browser

vitespin × Genitourinary × Clear all

NCT01147536 2021-06-03

Study of Vitespen (HSPPC-96, Oncophage ®) for Immune Response Assessment in Participants With Resectable Renal Cell Carcinoma at Intermediate Risk of Recurrence

Phase 2 Terminated

12 enrolled 5 charts

Carcinoma, Renal Cell

NCT00126178 2012-09-07

Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney Cancer

Phase 3 Terminated

Carcinoma, Renal Cell, Kidney Neoplasms